NDC 61755-056-01
LYNOZYFIC 200 mg/10mL
linvoseltamab-gcpt · INJECTION, SOLUTION, CONCENTRATE
LYNOZYFIC is a injection, solution, concentrate containing linvoseltamab-gcpt at a strength of 200 mg/10mL. Manufactured by Regeneron Pharmaceuticals, Inc..
Key Facts
- Brand Name
- LYNOZYFIC
- Generic Name
- linvoseltamab-gcpt
- NDC Code (Package)
61755-056-01- NDC Code (Product)
61755-056- Manufacturer
- Regeneron Pharmaceuticals, Inc.
- Strength
- 200 mg/10mL
- Dosage Form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761400
- Drug Class
- Bispecific B Cell Maturation Antigen-directed CD3 T Cell Engager [EPC]
- Marketing Start
- 07/02/2025
Recall History
No Recall HistoryView Full Drug Page
LYNOZYFIC — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.